Latest Pharmaceutical industry in India Stories

2014-01-29 23:35:14

Gallus BioPharmaceuticals, a premier pure-play biologics contract manufacturing organization, has completed a second expansion of its Process Development facility at its headquarters in St. Louis, Missouri. This expansion provides additional laboratory space and state-of-the-art instrumentation to support Gallus’ growth and commitment to leading pharma and biotech clients in the development of new biotherapeutics. St. Louis, Missouri (PRWEB) January 29, 2014 Gallus BioPharmaceuticals,...

2014-01-24 23:04:25

GIA announces the release of a trend report on Biobetters. Market for Biobetters is projected to witness strong growth led by increasing R&D investments in improving the therapeutic performance of existing and known biological molecules. San Jose, California (PRWEB) January 24, 2014 Follow us on LinkedIn – Biobetters or biosuperiors are novel molecules derived from successful, approved biologic products customized to enhance its overall efficacy. Biobetters are developed to offer...

2014-01-20 12:24:57

LONDON, Jan. 20, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Analyzing the Global Market for Active Pharmaceutical Ingredients The global market for active pharmaceutical ingredients has been growing steadily in recent years. However, the recent economic recession slowed down the growth of the industry as investments made by the major players went down significantly. Furthermore with a large number of blockbuster drugs going off patent by the...

2014-01-10 12:25:31

DUBLIN, Jan. 10, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/qhnxt9/biotechnology) has announced the addition of the "2013 Report on the International Biotechnology Market - Industry Analysis, Size, Share, Growth, Trends and Forecast to 2017" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The biotechnology market is primarily driven by the regulatory support provided by governments of various countries,...

2014-01-08 12:29:08

LONDON, Jan. 8, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Global Dermatophytic Onychomycosis Therapeutics Market 2012-2016 TechNavio's analysts forecast the Global Dermatophytic Onychomycosis Therapeutics market to grow at a CAGR of 7.28 percent over the period 2012-2016. One of the key factors contributing to this market growth is the strong and promising pipeline. The Global Dermatophytic Onychomycosis Therapeutics market has also been...

2014-01-08 08:29:06

SHANGHAI, Jan. 8, 2014 /PRNewswire/ -- Eddingpharm today announced that an asset purchase agreement (APA) has been signed with ACT Biotech, Inc. (ACT Biotech), a biopharmaceutical company based in the United States. Eddingpharm acquired worldwide rights to three small molecule drug assets (Telatinib, ACTB1003, and ACTB1010) and other molecules from ACT Biotech. Eddingpharm made an upfront payment to ACT Biotech upon the closing of the transactions contemplated under the APA. ACT...

2014-01-07 08:29:50

INDIANAPOLIS, Jan. 7, 2014 /PRNewswire/ -- -- 2014 revenue anticipated to be between $19.2 billion and $19.8 billion. -- Earnings per share for 2014 are expected to be in the range of $2.77 - $2.85, reflecting the impact of patent expirations. -- 2014 net income and operating cash flow goals of $3.0 billion and $4.0 billion, respectively, are expected to be achieved. -- Company reaffirms commitment to maintain dividend at least at current level....

2014-01-06 08:25:28

WESTBOROUGH, Mass., Jan. 6, 2014 /PRNewswire/ -- RXi Pharmaceuticals Corporation (OTCQX: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted technologies, today announced that the Company's President and Chief Executive Officer, Dr. Geert Cauwenbergh, will present at the Biotech Showcase(TM) 2014 conference on Tuesday, January 14, 2014 at 9:30AM PST. Dr. Cauwenbergh will...

2013-12-18 23:20:25

The Research and Development industry is projected to see continual investment increases over the next five years, primarily in the chemical and life science industries. Avomeen Analytical Services remarks on these findings and some of the underlying causes for the R&D increase, including competitive product design, private funding, and patents. (PRWEB) December 18, 2013 End of the year reports show that, overall, 2013 research and development (R&D) expenditures have stayed...

Word of the Day
  • A murmuring sound; a rushing or whistling sound, like that of the wind; a deep sigh.
  • A gentle breeze; a waft; a breath.
  • Any rumor that engages general attention.
  • A cant or whining mode of speaking, especially in preaching or praying; the chant or recitative characteristic of the old Presbyterians in Scotland.
  • To make a rushing, whistling, or sighing sound; emit a hollow murmur; murmur or sigh like the wind.
  • To breathe in or as in sleep.
  • To utter in a whining or monotonous tone.
According to the OED, from the 16th century, this word is 'almost exclusively Scots and northern dialect until adopted in general literary use in the 19th.'